C-Control: efficacy and safety of therapy with rosuvastatin in statin-naive and in statin-switched patients

Study identifier:NIS-CCH-CRE-2007/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

C-Control: efficacy and safety of therapy with rosuvastatin in statin-naive and in statin-switched patients

Medical condition

Hypercholesteremia

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

3392

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Feb 2007

Primary Completion Date: -

Study Completion Date: 01 Jan 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Pt with hypercholesteremia Patients treated with CRESTOR because of hypercholesteremia	-

"There is no result for the study"

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=757&filename=CSR-NIS-CCH-CRE-2007-1.pdf
Download
CSR-NIS-CCH-CRE-2007-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Switzerland Clinical Study Information

41-41-725-7575

madeleine.billeter@astrazeneca.com

C-Control: efficacy and safety of therapy with rosuvastatin in statin-naive and in statin-switched patients

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=757&filename=CSR-NIS-CCH-CRE-2007-1.pdf

CSR-NIS-CCH-CRE-2007-1.pdf

Trial Results Summaries

Contacts

Contact